EPM2A Antikörper (N-Term) (HRP)
-
- Target Alle EPM2A Antikörper anzeigen
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EPM2A Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Protein A purified
- Immunogen
-
KLH conjugated synthetic peptide selected from the N-terminal region of human EPM2A.
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product EPM2A Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, IHC
Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.2. No preservative added (azide free)
- Konservierungsmittel
- Azide free
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
- Haltbarkeit
- 6 months
-
- Target
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
- Andere Bezeichnung
- EPM2A / Laforin (EPM2A Produkte)
- Synonyme
- TG-B antikoerper, Tg(TcraK,TcrbK)TG-BFlv antikoerper, EPM2 antikoerper, MELF antikoerper, laforin antikoerper, EPM2A, laforin glucan phosphatase antikoerper, epilepsy, progressive myoclonic epilepsy, type 2 gene alpha antikoerper, EPM2A antikoerper, Epm2a antikoerper
- Hintergrund
-
Name/Gene ID: EPM2A
Subfamily: Laforin
Family: Protein Phosphatase
Synonyms: EPM2A, EPM2, LAFPTPase, LDE, Lafora PTPase, MELF, Laforin, LD - Gen-ID
- 7957
- Pathways
- Cellular Glucan Metabolic Process
-